A paper published by William Ruyechan, PhD, is being reviewed by Faculty of 1000 (F1000), a service that identifies and evaluates the most important articles in biology and medical research publications.
A UB MD/PhD candidate is lead author on a paper describing how drug-resistant viruses may be thwarted by a potent, immune-boosting payload delivered to cells by gold nanorods.
Vietnam War-era veterans exposed to Agent Orange appear to have significantly more Graves’ disease, a thyroid disorder, than veterans with no exposure.
The Cystic Fibrosis Center located in Women and Children’s Hospital of Buffalo, a UB-affiliated teaching hospital, is the first site to begin recruiting patients for a 48-week international clinical trial of a promising investigational treatment for cystic fibrosis (CF).